Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 263


Treatment of Collagen-Induced Arthritis Using Immune Modulatory Properties of Human Mesenchymal Stem Cells.

Park KH, Mun CH, Kang MI, Lee SW, Lee SK, Park YB.

Cell Transplant. 2016;25(6):1057-72. doi: 10.3727/096368915X687949. Epub 2015 Apr 7.


Adoptive transfer of human gingiva-derived mesenchymal stem cells ameliorates collagen-induced arthritis via suppression of Th1 and Th17 cells and enhancement of regulatory T cell differentiation.

Chen M, Su W, Lin X, Guo Z, Wang J, Zhang Q, Brand D, Ryffel B, Huang J, Liu Z, He X, Le AD, Zheng SG.

Arthritis Rheum. 2013 May;65(5):1181-93. doi: 10.1002/art.37894.


Therapeutic potential of human umbilical cord mesenchymal stem cells in the treatment of rheumatoid arthritis.

Liu Y, Mu R, Wang S, Long L, Liu X, Li R, Sun J, Guo J, Zhang X, Guo J, Yu P, Li C, Liu X, Huang Z, Wang D, Li H, Gu Z, Liu B, Li Z.

Arthritis Res Ther. 2010;12(6):R210. doi: 10.1186/ar3187. Epub 2010 Nov 16.


Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells.

González MA, Gonzalez-Rey E, Rico L, Büscher D, Delgado M.

Arthritis Rheum. 2009 Apr;60(4):1006-19. doi: 10.1002/art.24405.


Comparable therapeutic potential of umbilical cord mesenchymal stem cells in collagen-induced arthritis to TNF inhibitor or anti-CD20 treatment.

Sun Y, Kong W, Huang S, Shi B, Zhang H, Chen W, Zhang H, Zhao C, Tang X, Yao G, Feng X, Sun L.

Clin Exp Rheumatol. 2017 Mar-Apr;35(2):288-295. Epub 2017 Jan 15.


Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.

Joosten LA, Lubberts E, Helsen MM, Saxne T, Coenen-de Roo CJ, Heinegård D, van den Berg WB.

Arthritis Res. 1999;1(1):81-91. Epub 1999 Oct 26.


Adipose-Derived Mesenchymal Stem Cells Prevent Systemic Bone Loss in Collagen-Induced Arthritis.

Garimella MG, Kour S, Piprode V, Mittal M, Kumar A, Rani L, Pote ST, Mishra GC, Chattopadhyay N, Wani MR.

J Immunol. 2015 Dec 1;195(11):5136-48. doi: 10.4049/jimmunol.1500332. Epub 2015 Nov 4.


Human umbilical cord blood-stem cells direct macrophage polarization and block inflammasome activation to alleviate rheumatoid arthritis.

Shin TH, Kim HS, Kang TW, Lee BC, Lee HY, Kim YJ, Shin JH, Seo Y, Won Choi S, Lee S, Shin K, Seo KW, Kang KS.

Cell Death Dis. 2016 Dec 22;7(12):e2524. doi: 10.1038/cddis.2016.442.


Influence of polysaccharide fractions isolated from Caltha palustris L. on the cellular immune response in collagen-induced arthritis (CIA) in mice. A comparison with methotrexate.

Suszko A, Obmińska-Mrukowicz B.

J Ethnopharmacol. 2013 Jan 9;145(1):109-17. doi: 10.1016/j.jep.2012.10.038. Epub 2012 Nov 1.


Survival and biodistribution of xenogenic adipose mesenchymal stem cells is not affected by the degree of inflammation in arthritis.

Toupet K, Maumus M, Luz-Crawford P, Lombardo E, Lopez-Belmonte J, van Lent P, Garin MI, van den Berg W, Dalemans W, Jorgensen C, Noël D.

PLoS One. 2015 Jan 5;10(1):e0114962. doi: 10.1371/journal.pone.0114962. eCollection 2015. Erratum in: PLoS One. 2015;10(3):e0120406.


Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced arthritis.

Augello A, Tasso R, Negrini SM, Cancedda R, Pennesi G.

Arthritis Rheum. 2007 Apr;56(4):1175-86.


Comparison of drug and cell-based delivery: engineered adult mesenchymal stem cells expressing soluble tumor necrosis factor receptor II prevent arthritis in mouse and rat animal models.

Liu LN, Wang G, Hendricks K, Lee K, Bohnlein E, Junker U, Mosca JD.

Stem Cells Transl Med. 2013 May;2(5):362-75. doi: 10.5966/sctm.2012-0135. Epub 2013 Apr 16.


Intravenous delivery of adipose-derived mesenchymal stromal cells attenuates acute radiation-induced lung injury in rats.

Jiang X, Jiang X, Qu C, Chang P, Zhang C, Qu Y, Liu Y.

Cytotherapy. 2015 May;17(5):560-70. doi: 10.1016/j.jcyt.2015.02.011. Epub 2015 Mar 17.


Distinct immunomodulatory and migratory mechanisms underpin the therapeutic potential of human mesenchymal stem cells in autoimmune demyelination.

Payne NL, Sun G, McDonald C, Layton D, Moussa L, Emerson-Webber A, Veron N, Siatskas C, Herszfeld D, Price J, Bernard CC.

Cell Transplant. 2013;22(8):1409-25. doi: 10.3727/096368912X657620. Epub 2012 Oct 4.


Bone marrow CD11b(+)F4/80(+) dendritic cells ameliorate collagen-induced arthritis through modulating the balance between Treg and Th17.

Zhang L, Fu J, Sheng K, Li Y, Song S, Li P, Song S, Wang Q, Chen J, Yu J, Wei W.

Int Immunopharmacol. 2015 Mar;25(1):96-105. doi: 10.1016/j.intimp.2015.01.014. Epub 2015 Jan 22.


Comparison of Adipose-Derived and Bone Marrow Mesenchymal Stromal Cells in a Murine Model of Crohn's Disease.

Xie M, Qin H, Luo Q, He X, He X, Lan P, Lian L.

Dig Dis Sci. 2017 Jan;62(1):115-123. doi: 10.1007/s10620-016-4166-6. Epub 2016 Apr 23.


Comparison of the anti-inflammatory effects of induced pluripotent stem cell-derived and bone marrow-derived mesenchymal stromal cells in a murine model of corneal injury.

Yun YI, Park SY, Lee HJ, Ko JH, Kim MK, Wee WR, Reger RL, Gregory CA, Choi H, Fulcher SF, Prockop DJ, Oh JY.

Cytotherapy. 2017 Jan;19(1):28-35. doi: 10.1016/j.jcyt.2016.10.007. Epub 2016 Nov 10.


Mesenchymal stem cells alleviate TNBS-induced colitis by modulating inflammatory and autoimmune responses.

Chen QQ, Yan L, Wang CZ, Wang WH, Shi H, Su BB, Zeng QH, Du HT, Wan J.

World J Gastroenterol. 2013 Aug 7;19(29):4702-17. doi: 10.3748/wjg.v19.i29.4702.


Equine mesenchymal stem cells inhibit T cell proliferation through different mechanisms depending on tissue source.

Carrade Holt DD, Wood JA, Granick JL, Walker NJ, Clark KC, Borjesson DL.

Stem Cells Dev. 2014 Jun 1;23(11):1258-65. doi: 10.1089/scd.2013.0537. Epub 2014 Mar 4.


Cell source-dependent in vivo immunosuppressive properties of mesenchymal stem cells derived from the bone marrow and synovial fluid of minipigs.

Lee WJ, Hah YS, Ock SA, Lee JH, Jeon RH, Park JS, Lee SI, Rho NY, Rho GJ, Lee SL.

Exp Cell Res. 2015 May 1;333(2):273-88. doi: 10.1016/j.yexcr.2015.03.015. Epub 2015 Mar 27.

Supplemental Content

Support Center